Paper422252
[Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].
Bauernfeind A and 2 others. Infection, 1979. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)]. Papers, record 422252. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/422252
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carbenicillin | Major topic |
| Penicillins | Major topic |
| Pseudomonas Infections | Major topic |
| Ticarcillin | Major topic |
| Aminoglycosides | |
| Humans | |
| Microbial Sensitivity Tests | |
| Penicillin Resistance |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18,083 | Azlocillin: in vitro studies of a new semisynthetic penicillin. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/18083 | PubMed |
| 2 | 977,133 | [Pharmacokinetics of azlocillin, a new semisynthetic, wide-spectrum antibiotic (author's transl)]. | Infection | 1976 | https://conductscience.org/library/papers/977133 | PubMed |
| 3 | 795,372 | Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/795372 | PubMed |
| 4 | 412,776 | [Bacteria and resistance patterns in bacteriuria of hospitalized patients (author's transl)]. | Immun Infekt | 1977 | https://conductscience.org/library/papers/412776 | PubMed |
| 5 | 4,218,163 | [Ticarcillin: in-vitro activity and pharmacokinetics (author's transl)]. | Dtsch Med Wochenschr | 1974 | https://conductscience.org/library/papers/4218163 | PubMed |
| 6 | 4,974,900 | [Studies on Pseudomonas aeruginosa in surface water. I. Sources]. | Arch Hyg Bakteriol | 1968 | https://conductscience.org/library/papers/4974900 | PubMed |
| 7 | 4,210,892 | Preliminary clinical experience with ticarcillin (BRL 2288) in 101 patients treated for severe respiratory infections. | Chemotherapy | 1974 | https://conductscience.org/library/papers/4210892 | PubMed |
| 8 | 984,764 | Comparative activity in vitro of ticarcillin, BL-P1654, and carbenicillin. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984764 | PubMed |
| 9 | 4,208,532 | Activity of carbenicillin and ticarcillin against Pseudomonas aeruginosa compared by paired in vitro tests. | Infection | 1974 | https://conductscience.org/library/papers/4208532 | PubMed |
| 10 | 418,604 | [Modified procedure for pyocin typing of Pseudomonas aeruginosa (author's transl)]. | Zentralbl Bakteriol Orig A | 1978 | https://conductscience.org/library/papers/418604 | PubMed |
| 11 | 6,069,557 | New semi-synthetic penicillin active against Pseudomonas pyocyanea. | Nature | 1967 | https://conductscience.org/library/papers/6069557 | PubMed |
| 12 | 4,995,575 | The fate of ingested Pseudomonas aeruginosa in normal persons. | J Med Microbiol | 1969 | https://conductscience.org/library/papers/4995575 | PubMed |
| 13 | 5,000,263 | -carboxy-3-thienylmethylpenicillin (BRL 2288), a new semisynthetic penicillin: in vitro evaluation. | Antimicrob Agents Chemother (Bethesda) | 1970 | https://conductscience.org/library/papers/5000263 | PubMed |
| 14 | 4,162,795 | Faecal carriage of Pseudomonas aeruginosa in hospital patients. Possible spread from patient to patient. | Lancet | 1966 | https://conductscience.org/library/papers/4162795 | PubMed |
| 16 | 4,210,893 | Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic. | Chemotherapy | 1974 | https://conductscience.org/library/papers/4210893 | PubMed |
| 17 | 418,741 | Suggested procedure allowing use of plastic petri dishes in bacteriocin typing. | Appl Environ Microbiol | 1978 | https://conductscience.org/library/papers/418741 | PubMed |
| 18 | 334,673 | [Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)]. | Infection | 1977 | https://conductscience.org/library/papers/334673 | PubMed |
| 19 | 410,735 | [Azlocillin--a new penicillin against Pseudomonas aeruginosa and other gram-negative bacteria]. | Infection | 1977 | https://conductscience.org/library/papers/410735 | PubMed |
| 20 | 4,990,646 | Observations on the intestinal carriage of Pseudomonas aeruginosa. | J Med Microbiol | 1970 | https://conductscience.org/library/papers/4990646 | PubMed |
| 21 | 825,582 | Ticarcillin for treatment of serious infections with gram-negative bacteria. | J Infect Dis | 1976 | https://conductscience.org/library/papers/825582 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 6,286,502 | [Therapy with cefotaxime-cefotaxime/ticarcillin for bronchopulmonary infections in patients under intensive care. (author's transl)]. | Infection | 1982 | https://conductscience.org/library/papers/6286502 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/422252
GET https://conductscience.org/api/papers/v1/422252/references?page=2